blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1673362

EP1673362 - METHOD FOR PRODUCING CHROMANE DERIVATIVES THAT ARE DEVOID OF ENANTIOMERS AND ARE SUBSTITUTED IN POSITION 2 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.04.2008
Database last updated on 16.09.2024
Most recent event   Tooltip04.04.2008Application deemed to be withdrawnpublished on 07.05.2008  [2008/19]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
[2006/26]
Inventor(s)01 / DEVANT, Ralf DI
verstorben / DE
02 / BOKEL, Heinz-Hermann
Gundolfstrasse 2
64287 Darmstadt / DE
03 / REUBOLD, Helmut
Südring 20
64732 Bad König / DE
04 / PFLUG, Herbert
Carlo-Mierendorff-Strasse 8
64354 Reinheim / DE
05 / KNIERIEME, Ralf
Sudetenstrasse 16
64846 Gross-Zimmern / DE
 [2006/26]
Application number, filing date04765299.516.09.2004
[2006/26]
WO2004EP10399
Priority number, dateDE200314825716.10.2003         Original published format: DE 10348257
[2006/26]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2005037817
Date:28.04.2005
Language:DE
[2005/17]
Type: A2 Application without search report 
No.:EP1673362
Date:28.06.2006
Language:DE
The application published by WIPO in one of the EPO official languages on 28.04.2005 takes the place of the publication of the European patent application.
[2006/26]
Search report(s)International search report - published on:EP23.06.2005
ClassificationIPC:C07D311/58, C07D311/66
[2006/26]
CPC:
C07D311/66 (EP); C07D311/58 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/26]
Extension statesALNot yet paid
HRNot yet paid
LT17.02.2006
LV17.02.2006
MKNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG VON ENANTIOMERENREINEN, IN 2-POSITION SUBSTITUIERTEN CHROMANDERIVATEN[2006/26]
English:METHOD FOR PRODUCING CHROMANE DERIVATIVES THAT ARE DEVOID OF ENANTIOMERS AND ARE SUBSTITUTED IN POSITION 2[2006/26]
French:PROCEDE DE PRODUCTION DE DERIVES DE CHROMANE SUBSTITUES EN POSITION 2, EXEMPTS D'ENANTIOMERES[2006/26]
Entry into regional phase17.02.2006National basic fee paid 
17.02.2006Designation fee(s) paid 
17.02.2006Examination fee paid 
Examination procedure17.02.2006Examination requested  [2006/26]
04.07.2007Despatch of a communication from the examining division (Time limit: M04)
15.11.2007Application deemed to be withdrawn, date of legal effect  [2008/19]
19.12.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/19]
Fees paidRenewal fee
11.09.2006Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.09.200704   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - A. STREITWIESER, C.H. HEATHCOCK, organische chemie, WEINHEIM, VERLAG CHEMIE, (1980), XP002317016 [X] 1-7 * page 578, chapter 18.9.3.3, page 590, chapter 18.11.2, page 588, chapter 18.10.4, page 926, chapter 27.6.5 *
 [X]  - CH. B. CHAPLEO, "alpha-Adrenoreceptor Reagents. 2. Effects of Modification of the 1,4-Benzodioxan Ring System on alpha-Adrenoreceptor Activity", J. MED. CHEM., (1984), vol. 27, pages 570 - 576, XP002317015 [X] 1-7 * page 570, scheme I plus paragraph below *

DOI:   http://dx.doi.org/10.1021/jm00371a003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.